This image is not available for purchase in your country.

mRNA in lipid nanoparticles, conceptual illustration

mRNA in lipid nanoparticles, conceptual illustration

C053/1843

Rights Managed

64.5 MB (2.9 MB compressed)

4252 x 5299 pixels

36.1 x 45.0 cm ⏐ 14.2 x 17.7 in (300dpi)

This image is not available for purchase in your country.

Please contact your Account Manager if you have any query.

Credit

RAMON ANDRADE 3DCIENCIA / SCIENCE PHOTO LIBRARY RAMON ANDRADE 3DCIENCIA / SCIENCE PHOTO LIBRARY

Caption

mRNA in lipid nanoparticles, conceptual illustration. Close-up of molecules of mRNA (messenger ribonucleic acid, brown) encapsulated in lipid nanoparticles as utilised in RNA vaccines. These nanoparticles consist of a double membrane containing multiple different types of lipids, such as phospholipids, cholesterol, and PEGylated lipids. When injected into humans, the RNA will be taken up and read by the body's cells, causing them to produce copies of viral proteins. The viral proteins will provoke an immune response, priming the body against infection with the actual virus. The first RNA vaccine approved for human use, developed against the SARS-CoV-2 coronavirus by Pfizer/BioNTech, was approved in the UK on 2nd December 2020.

Release details

Model release not required. Property release not required.

 {{ i.shot_duration ? i.shot_duration + ' ' : '' }}{{ i.shot_uhd ? '4K ' : i.hires ? 'HD ' : '' }}{{ i.spl_number }} R{{ i.license }}

  • basket icon
  • Calculate price calculator icon
  • Add to board lightbox icon